KLYGEFA
ALEXION PHARM · GEFURULIMAB-GAKS
Open FDA's page for this record- Application number
- BLA761488
- Sponsor name
- ALEXION PHARM
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20261113
- Review priority
- STANDARD
- Submission class code
- TYPE 1
- Submission class code description
- Type 1 - New Molecular Entity
- Submission property type
- Code
- Orphan
- Application docs
- ID
- 87700
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761488s000lbl.pdf
- Date
- 20261113
- Type
- Label
- ID
- 87733
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/761488Orig1s000ltr.pdf
- Date
- 20261117
- Type
- Letter
- Products
- Product number
- 001
- Reference drug
- No
- Brand name
- KLYGEFA
- Reference standard
- No
- Dosage form
- SOLUTION
- Route
- INJECTION
- Marketing status
- Prescription
- Active ingredients
- Name
- GEFURULIMAB-GAKS
- Strength
- 300MG
